Repligen Corp (RGEN) Swings to Q3 Loss
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $167.60 -1.19%
Revenue Growth %: +9.4%
Financial Fact:
Investment income: 97K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +9.4%
Financial Fact:
Investment income: 97K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Repligen Corp (NASDAQ: RGEN) reported Q3 EPS of ($0.07), versus $0.01 reported last year. Revenue for the quarter came in at $7.17 million, versus $7.07 million reported last year.
For earnings history and earnings-related data on Repligen Corp (RGEN) click here.
For earnings history and earnings-related data on Repligen Corp (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- UBS Upgrades E.ON SE (EOAN:GR) (EONGY) to Buy
- Ardent Health revises 2025 non-GAAP figures after SEC staff talks
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
